Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMB

Aaron T Wecksler1, Sung Hee Hwang, Hiromi I Wettersten

  • 1Departments of aEntomology and Nematology bNeurobiology, Physiology and Behavior, University of California Davis, Davis cUC Davis Comprehensive Cancer Center dDepartment of Internal Medicine, Davis Medical Center, Division of Nephrology, University of California eDepartment of Biochemistry and Molecular Medicine, University of California Davis School of Medicine fUS Department of Veterans' Affairs Medical Center, Sacramento, California, USA.

Anti-Cancer Drugs
|February 15, 2014
PubMed